{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T16:23:53Z","timestamp":1791563033438,"version":"4.3.4"},"reference-count":70,"publisher":"BMJ","issue":"4","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"unspecified","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Shanghai Key Laboratory of Diabetes Mellitus","award":["20DZ2270300"],"award-info":[{"award-number":["20DZ2270300"]}]},{"DOI":"10.13039\/501100012151","name":"Sanming Project of Medicine in Shenzhen","doi-asserted-by":"crossref","award":["SZSM202311019"],"award-info":[{"award-number":["SZSM202311019"]}],"id":[{"id":"10.13039\/501100012151","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0523300"],"award-info":[{"award-number":["2024ZD0523300"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Key Clinical Specialty Capacity Building for Endocrine and Metabolic Diseases","award":["Z155080000004"],"award-info":[{"award-number":["Z155080000004"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Fam Med Com Health"],"accepted":{"date-parts":[[2025,11,25]]},"published-print":{"date-parts":[[2025,10]]},"abstract":"<jats:p>In recent years, the prevalence of diabetes in China has increased significantly, and approximately 11.9% of Chinese adults had diabetes in 2020. Moreover, there are several rigorous challenges in diabetes prevention and glycaemic control, especially at the primary medical care level. In order to guide primary healthcare providers in providing comprehensive and continuous care to affected patients, the Office for Primary Diabetes Care of the National Basic Public Health Service Program and the Chinese Diabetes Society issued national guidelines for the prevention and control of diabetes at the primary care level in 2025. The management objects were adults with type 2 diabetes aged \u226518 years. The main contents include basic requirements for management, health management process, diagnosis, screening, evaluation, treatment, recognition and management of acute complications, traditional Chinese medicine, referral and health management and education.<\/jats:p>","DOI":"10.1136\/fmch-2025-003765","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:20:33Z","timestamp":1767799233000},"page":"e003765","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":9,"title":["Guidelines on primary healthcare for type 2 diabetes in China, 2025"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6244-2168","authenticated-orcid":false,"given":"Weiping","family":"Jia","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, the Office for Primary Diabetes Care of the National Basic Public Health Service Program, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1064-1261","authenticated-orcid":false,"given":"Dalong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Drum Tower Hospital Clinical College of Nanjing Medical University, Nanjing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2609-8387","authenticated-orcid":false,"given":"Lixin","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Beijing Hospital, National Center for Gerontology, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5682-2340","authenticated-orcid":false,"given":"Liming","family":"Chen","sequence":"additional","affiliation":[{"name":"Tianjin Medical University Chu Hisen-I Memorial Hospital, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8725-5433","authenticated-orcid":false,"given":"Chun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, Shanghai Sixth People\u2019s Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai Diabetes Institute, the Office for Primary Diabetes Care of the National Basic Public Health Service Program, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-5783","authenticated-orcid":false,"given":"Jun","family":"Song","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2025123022253174000_13.4.e003765.1","unstructured":"Bureau of Disease Prevention and Control NHC . Report on nutrition and chronic diseases of the chinese population (2020). Beijing People\u2019s Health Publishing House; 2021."},{"key":"2025123022253174000_13.4.e003765.2","doi-asserted-by":"crossref","first-page":"4296","DOI":"10.1038\/s41467-023-39864-w","article-title":"Prevalence of diabetic retinopathy and vision-threatening diabetic retinopathy in adults with diabetes in China","volume":"14","author":"Hou","year":"2023","journal-title":"Nat Commun"},{"key":"2025123022253174000_13.4.e003765.3","article-title":"Prevalence of chronic kidney disease among Chinese adults with diabetes: a nationwide population-based cross-sectional study","volume":"55","author":"Jia","year":"2025","journal-title":"Lancet Reg Health West Pac"},{"key":"2025123022253174000_13.4.e003765.4","unstructured":"Office of the Leading Group for Deepening Medical and Health System Reform of the State Council NHaFPC, National Development and Reform Committee, etc . Guiding opinions on promoting family doctor contracted services 2016-05-25."},{"key":"2025123022253174000_13.4.e003765.5","unstructured":"Notice of the national health and family planning committee on the issuance of the national primary public health service specifications (third edition) 2017-02-28."},{"key":"2025123022253174000_13.4.e003765.6","first-page":"16","article-title":"Guideline for the prevention and treatment of diabetes mellitus in China","volume":"17","year":"2025","journal-title":"Chinese Journal of Diabetes"},{"key":"2025123022253174000_13.4.e003765.7","doi-asserted-by":"publisher","DOI":"10.2337\/dc18-1131"},{"key":"2025123022253174000_13.4.e003765.8","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/dia.2019.0251","article-title":"Time in Range Is Associated with Carotid Intima-Media Thickness in Type 2 Diabetes","volume":"22","author":"Lu","year":"2020","journal-title":"Diabetes Technology & Therapeutics"},{"key":"2025123022253174000_13.4.e003765.9","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-1862"},{"key":"2025123022253174000_13.4.e003765.10","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-147-6-200709180-00178"},{"key":"2025123022253174000_13.4.e003765.11","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-1727"},{"key":"2025123022253174000_13.4.e003765.12","article-title":"Metformin monotherapy for type 2 diabetes mellitus","volume":"2005","author":"Saenz","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"2025123022253174000_13.4.e003765.13","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"The Lancet"},{"key":"2025123022253174000_13.4.e003765.14","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0719"},{"key":"2025123022253174000_13.4.e003765.15","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-2856-6"},{"key":"2025123022253174000_13.4.e003765.16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0806470"},{"key":"2025123022253174000_13.4.e003765.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802987"},{"key":"2025123022253174000_13.4.e003765.18","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200017050-00007"},{"key":"2025123022253174000_13.4.e003765.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079421","article-title":"Comparisons of the Efficacy of Alpha Glucosidase Inhibitors on Type 2 Diabetes Patients between Asian and Caucasian","volume":"8","author":"Cai","year":"2013","journal-title":"PLoS ONE"},{"key":"2025123022253174000_13.4.e003765.20","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-8587(17)30309-1","article-title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Holman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025123022253174000_13.4.e003765.21","doi-asserted-by":"publisher","DOI":"10.1089\/152091503763816445"},{"key":"2025123022253174000_13.4.e003765.22","first-page":"826","article-title":"A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Pioglitazone Hydrochloride in Combination with Sulfonylureas in the Treatment of Type 2 Diabetes Mellitus","volume":"50","author":"Lv Zhaohui","year":"2011","journal-title":"Chinese Journal of Internal Medicine"},{"key":"2025123022253174000_13.4.e003765.23","first-page":"388","article-title":"A Multicenter Clinical Study on the Efficacy and Safety of Pioglitazone Hydrochloride in the Treatment of Type 2 Diabetes Mellitus","volume":"41","author":"Pan Changyu","year":"2002","journal-title":"Chinese Journal of Internal Medicine"},{"key":"2025123022253174000_13.4.e003765.24","doi-asserted-by":"crossref","DOI":"10.1186\/s12933-020-01056-x","article-title":"Pioglitazone for primary stroke prevention in Asian patients with type 2 diabetes and cardiovascular risk factors: a retrospective study","volume":"19","author":"Hung","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"2025123022253174000_13.4.e003765.25","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12511"},{"key":"2025123022253174000_13.4.e003765.26","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.12875","article-title":"Efficacy and safety of fixed-dose combination therapy, alogliptin plus metformin, in Asian patients with type 2 diabetes: A phase 3 trial","volume":"19","author":"Ji","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"2025123022253174000_13.4.e003765.27","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-5491.2008.02391.x"},{"key":"2025123022253174000_13.4.e003765.28","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2008.10.009"},{"key":"2025123022253174000_13.4.e003765.29","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.1306"},{"key":"2025123022253174000_13.4.e003765.30","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.12659\/MSM.894026","article-title":"Effect of Linagliptin on Glycemic Control in Chinese Patients with Newly-Diagnosed, Drug-Na\u00efve Type 2 Diabetes Mellitus: A Randomized Controlled Trial","volume":"21","author":"Wu","year":"2015","journal-title":"Med Sci Monit"},{"key":"2025123022253174000_13.4.e003765.31","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12425"},{"key":"2025123022253174000_13.4.e003765.32","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12456"},{"key":"2025123022253174000_13.4.e003765.33","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2016.1277200"},{"key":"2025123022253174000_13.4.e003765.34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1753-0407.2012.00213.x"},{"key":"2025123022253174000_13.4.e003765.35","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2011.07.035"},{"key":"2025123022253174000_13.4.e003765.36","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/j.1463-1326.2012.01593.x","article-title":"Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus","volume":"14","author":"Pan","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"2025123022253174000_13.4.e003765.37","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.12284"},{"key":"2025123022253174000_13.4.e003765.38","doi-asserted-by":"publisher","DOI":"10.1185\/03007995.2013.805123"},{"key":"2025123022253174000_13.4.e003765.39","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.12585"},{"key":"2025123022253174000_13.4.e003765.40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/1753-0407.12303","article-title":"Vildagliptin as add-on therapy to insulin improves glycemic control without increasing risk of hypoglycemia in Asian, predominantly Chinese, patients with type 2 diabetes mellitus","volume":"8","author":"Ning","year":"2016","journal-title":"J Diabetes"},{"key":"2025123022253174000_13.4.e003765.41","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1111\/dom.15601","article-title":"Retagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes inadequately controlled with metformin: A multicentre, randomized, double-blind, placebo-controlled, phase 3 trial","volume":"26","author":"Guo","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"2025123022253174000_13.4.e003765.42","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1600827"},{"key":"2025123022253174000_13.4.e003765.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1611925"},{"key":"2025123022253174000_13.4.e003765.44","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812389"},{"key":"2025123022253174000_13.4.e003765.45","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2022190"},{"key":"2025123022253174000_13.4.e003765.46","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa943"},{"key":"2025123022253174000_13.4.e003765.47","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1007\/s00125-021-05623-z","article-title":"Ertugliflozin, renoprotection and potential confounding by muscle wasting","volume":"65","author":"Cherney","year":"2022","journal-title":"Diabetologia"},{"key":"2025123022253174000_13.4.e003765.48","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024816"},{"key":"2025123022253174000_13.4.e003765.49","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2204233"},{"key":"2025123022253174000_13.4.e003765.50","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1811744"},{"key":"2025123022253174000_13.4.e003765.51","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"2025123022253174000_13.4.e003765.52","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025123022253174000_13.4.e003765.53","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2403347"},{"key":"2025123022253174000_13.4.e003765.54","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00125-023-06057-5","article-title":"Cardiovascular and mortality outcomes with GLP-1 receptor agonists vs other glucose-lowering drugs in individuals with NAFLD and type 2 diabetes: a large population-based matched cohort study","volume":"67","author":"Krishnan","year":"2024","journal-title":"Diabetologia"},{"key":"2025123022253174000_13.4.e003765.55","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S2213-8587(15)00041-8","article-title":"Comparison of thrice-daily premixed insulin (insulin lispro premix) with basal-bolus (insulin glargine once-daily plus thrice-daily prandial insulin lispro) therapy in east Asian patients with type 2 diabetes insufficiently controlled with twice-daily premixed insulin: an open-label, randomised, controlled trial","volume":"3","author":"Jia","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2025123022253174000_13.4.e003765.56","first-page":"885","article-title":"Committee of Cardio-Cerebro-Vascular Diseases of Gerontological Society of China, Association CCoCPoCMD. Chinese expert consensus on the diagnosis and treatment of hypertension in the elderly (2017)","volume":"56","year":"2017","journal-title":"Chinese Journal of Internal Medicine"},{"key":"2025123022253174000_13.4.e003765.57","doi-asserted-by":"publisher","DOI":"10.3969\/j.issn.1000-3614.2023.03.001"},{"key":"2025123022253174000_13.4.e003765.58","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.atherosclerosis.2008.03.001","article-title":"Optimal waist circumference cutoffs for abdominal obesity in Chinese","volume":"201","author":"Bao","year":"2008","journal-title":"Atherosclerosis"},{"key":"2025123022253174000_13.4.e003765.59","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-S008"},{"key":"2025123022253174000_13.4.e003765.60","doi-asserted-by":"publisher","DOI":"10.2337\/ds17-0044"},{"key":"2025123022253174000_13.4.e003765.61","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-024-03139-8"},{"key":"2025123022253174000_13.4.e003765.62","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-023-02702-z"},{"key":"2025123022253174000_13.4.e003765.63","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1038\/s41467-021-23458-5","article-title":"A deep learning system for detecting diabetic retinopathy across the disease spectrum","volume":"12","author":"Dai","year":"2021","journal-title":"Nat Commun"},{"key":"2025123022253174000_13.4.e003765.64","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046966","article-title":"Application of the Ipswich Touch Test for diabetic peripheral neuropathy screening: a systematic review and meta-analysis","volume":"11","author":"Zhao","year":"2021","journal-title":"BMJ Open"},{"key":"2025123022253174000_13.4.e003765.65","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamainternmed.2024.1190","article-title":"Jinlida for Diabetes Prevention in Impaired Glucose Tolerance and Multiple Metabolic Abnormalities: The FOCUS Randomized Clinical Trial","volume":"184","author":"Ji","year":"2024","journal-title":"JAMA Intern Med"},{"key":"2025123022253174000_13.4.e003765.66","unstructured":"China Association of Chinese Medicine . Clinical guidelines for diagnosis and treatment of diabetes mellitus in traditional Chinese medicine. Beijing: China Press of Chinese Medicine, 2020."},{"key":"2025123022253174000_13.4.e003765.67","unstructured":"General Office of the National Health and Family Planning Committee OotSAoTCM. Notice on the Pilot Work of Hierarchical Diagnosis and Treatment of Hypertension and Diabetes.. 2015."},{"key":"2025123022253174000_13.4.e003765.68","doi-asserted-by":"crossref","first-page":"111564","DOI":"10.1016\/j.diabres.2024.111564","article-title":"Benefits of 12-month peer support for diabetes self management sustained at 18 months","volume":"209","author":"Liu","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"2025123022253174000_13.4.e003765.69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003754","article-title":"Evaluation of an mHealth-enabled hierarchical diabetes management intervention in primary care in China (ROADMAP): A cluster randomized trial","volume":"18","author":"Jia","year":"2021","journal-title":"PLoS Med"},{"key":"2025123022253174000_13.4.e003765.70","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMOA2102953\/SUPPL_FILE\/NEJMOA2102953_DISCLOSURES.PDF"}],"container-title":["Family Medicine and Community Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/fmch-2025-003765","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:20:39Z","timestamp":1767799239000},"score":1,"resource":{"primary":{"URL":"https:\/\/fmch.bmj.com\/lookup\/doi\/10.1136\/fmch-2025-003765"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":70,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10.1136\/fmch-2025-003765"],"URL":"https:\/\/doi.org\/10.1136\/fmch-2025-003765","relation":{},"ISSN":["2305-6983","2009-8774"],"issn-type":[{"value":"2305-6983","type":"print"},{"value":"2009-8774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10]]}}}